Sold out20.11 KWD
Bonviva 150Mg Tab 1's
Bonviva 150 mg Tablets contain ibandronic acid, a bisphosphonate medication used for the treatment of osteoporosis in postmenopausal women. It helps reduce bone loss and supports bone strength with a convenient once-monthly dosing schedule.
Take one tablet once monthly on the same day each month, as prescribed by a healthcare professional. Swallow the tablet whole with a full glass of plain water on an empty stomach, at least 60 minutes before food or drink. Remain upright for at least one hour after taking the tablet.
Ibandronic acid has been clinically shown to increase bone mineral density and reduce bone turnover in patients with osteoporosis. It is widely used in clinical practice for long-term management of bone loss in postmenopausal women.
Active ingredient: ibandronic acid 150 mg. Includes standard pharmaceutical excipients used in tablet formulation to ensure stability and effective absorption.
Helps reduce bone loss, supports stronger bones, lowers fracture risk, and offers the convenience of once-monthly dosing for osteoporosis management.
Germany
